Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia

Go back to Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia
(NASDAQ: BNGO) Delayed: 1.66 --0 (-0%)
Previous Close $1.66    52 Week High $ 
Open $1.66    52 Week Low $ 
Day High $1.66    P/E N/A 
Day Low $1.66    EPS $ 
Volume 637